Monday 4 May – Monday 11 May
On World Ovarian Cancer Day, 8 May, the Australian Government announced $16M for eight research projects, including drug development, genomics, early detection and patient-reported outcomes.
Alfred Health and the Royal Hobart Hospital have partnered to deliver a Phase I clinical trial using the teletrial model, with VCCC operational support.
WEHI researchers have developed a new way to understand which breast cancers will respond to a new class of anti-cancer agents. Also from WEHI, promising pre-clinical results from a Phase I trial combining venetoclax with current therapy for estrogen receptor-positive (ER+) breast cancer.
Monash University has received $1M from MRFF for two projects focusing on the ethical, legal and social issues concerning genomics. While the University of Tasmania is using MRFF funding for a citizen jury to examine community opinion on the use of gene-editing technologies.
